Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Nov 30, 2024 | (Q2)May 31, 2024 | (Q1)Feb 29, 2024 | (FY)Nov 30, 2023 | (Q4)Nov 30, 2023 | (Q3)Aug 31, 2023 | (Q2)May 31, 2023 | (Q1)Feb 28, 2023 | (FY)Nov 30, 2022 | (Q4)Nov 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 9.49%5.24B | 8.58%1.3B | 13.06%1.24B | 9.84%4.79B | 8.24%1.27B | 16.21%1.22B | 9.49%1.2B | 5.60%1.1B | 12.73%4.36B | 13.51%1.17B |
| Cost of revenue | 9.12%4.06B | 7.42%999.41M | 10.44%944.22M | 9.70%3.72B | 11.70%991.59M | 12.20%947.85M | 8.65%930.38M | 6.00%854.94M | 10.82%3.4B | 8.32%887.69M |
| Gross profit | 10.78%1.18B | 12.62%299.92M | 22.27%297M | 10.34%1.06B | -2.49%279.14M | 32.61%273.21M | 12.52%266.3M | 4.19%242.9M | 20.04%962.11M | 33.31%286.27M |
| Operating expense | 0.13%978.65M | 1.20%244.09M | -3.82%243.17M | 16.08%977.37M | 9.57%235.54M | 17.95%247.81M | 16.63%241.2M | 20.32%252.82M | 13.50%841.98M | 17.00%214.96M |
| Operating profit | 134.42%197.34M | 122.44%55.84M | 642.71%53.83M | -29.92%84.18M | -38.86%43.6M | 725.36%25.4M | -15.94%25.1M | -143.10%-9.92M | 101.44%120.13M | 129.97%71.31M |
| Net non-operating interest income (expenses) | -26.58%-12.98M | -22.38%-3.2M | -22.53%-2.71M | -33.18%-10.25M | -32.53%-2.69M | -33.90%-2.74M | -19.52%-2.61M | -53.82%-2.22M | -32.11%-7.7M | -66.89%-2.03M |
| Non-operating interest income | 684.62%102K | -86.67%4K | 200.00%9K | 62.50%13K | -12,700.00%-126K | 3,433.33%106K | 1,400.00%30K | 50.00%3K | -27.27%8K | 0.00%1K |
| Non-operating interest expense | 34.45%9.78M | 29.58%2.38M | 33.36%2.01M | 39.72%7.27M | 38.56%1.85M | 53.84%2.08M | 22.81%1.84M | 47.27%1.51M | 28.86%5.21M | 61.19%1.33M |
| Total other finance cost | 10.30%3.3M | 1.98%824K | 0.28%712K | 19.65%2.99M | 2.59%712K | 9.67%760K | 16.43%808K | 69.86%710K | 39.07%2.5M | 78.87%694K |
| Net investment income | 1.22%1.16M | 3.81%1.14M | 1.82%56K | 1.02M | 0 | 72K | 119.96%1.1M | 55K | ||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 0 | 7.06M | 0 | |||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -85.66%1.58M | -99.81%21K | 5K | 167.15%11.04M | 149.20%5.63M | -7.29%-5.86M | 11.26M | 0 | 2.03%-16.44M | -2,768.53%-11.45M |
| Less:Restructuring and mergern&acquisition | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---3.36M | --0 |
| Less:Other special charges | 86.04%-1.58M | ---21K | ---5K | -235.83%-11.34M | ---5.63M | 1.72%5.55M | ---- | ---- | -50.24%8.35M | --0 |
| Less:Write off | --0 | ---- | ---- | -97.34%304K | --0 | ---- | ---- | ---- | --11.45M | --11.45M |
| Other non-operating income (expenses) | -91.24%729K | -444.59%-4.08M | 661.41%2.27M | 24.97%8.32M | -99.57%27K | 2,466.32%6.82M | 426.22%1.18M | -33.78%298K | 2.70%6.66M | 22.92%6.27M |
| Income before tax | 85.07%187.84M | 39.06%48.58M | 553.88%53.39M | -2.17%101.5M | -16.34%53.68M | 328.01%24.64M | 25.21%34.93M | -152.29%-11.76M | 135.71%103.75M | 81.62%64.17M |
| Income tax | 17.09%63.2M | -7.97%18.54M | 1,473.93%21.61M | -7.48%53.97M | -59.90%16.44M | 920.24%16.01M | 89.34%20.15M | -84.13%1.37M | 280.35%58.34M | 226.76%41M |
| Net income | 162.27%124.64M | 103.16%30.04M | 341.90%31.77M | 4.64%47.52M | 60.74%37.24M | 197.46%8.63M | -14.34%14.79M | -194.89%-13.14M | 58.36%45.42M | 1.69%23.17M |
| Net income continuous operations | 162.27%124.64M | 103.14%30.04M | 341.91%31.78M | 4.64%47.52M | 60.75%37.24M | 197.46%8.63M | -14.33%14.79M | -194.89%-13.14M | 58.36%45.42M | 1.69%23.17M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 162.27%124.64M | 103.16%30.04M | 341.90%31.77M | 4.64%47.52M | 60.74%37.24M | 197.46%8.63M | -14.34%14.79M | -194.89%-13.14M | 58.36%45.42M | 1.69%23.17M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 162.27%124.64M | 103.16%30.04M | 341.90%31.77M | 4.64%47.52M | 60.74%37.24M | 197.46%8.63M | -14.34%14.79M | -194.89%-13.14M | 58.36%45.42M | 1.69%23.17M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 162.10%62.93 | 102.81%15.17 | 341.72%16.05 | 7.43%24.01 | 63.85%18.81 | 206.34%4.36 | -9.55%7.48 | -199.10%-6.64 | 59.76%22.35 | 3.33%11.48 |
| Diluted earnings per share | 162.65%61.54 | 98.38%14.82 | 335.99%15.67 | 7.87%23.43 | 64.52%18.36 | 203.66%4.25 | -7.54%7.4704 | -201.68%-6.64 | 62.57%21.72 | 5.18%11.16 |
| Dividend per share | 137.50%19 | 0 | 0 | 14.29%8 | 14.29%8 | 0 | 0 | 0 | 0.00%7 | 0.00%7 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |